Nebulizers market seen reaching $2.07 billion by 2030

The Business Research Company says the nebulizers market rose to $1.52 billion in 2026 and is projected to hit $2.07 billion by 2030, driven by telemedicine, home care and connected devices. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Nebulizers are becoming more important as respiratory disease rates rise and care shifts toward home-based and remote treatment. - The market’s projected climb to $2.07 billion by 2030 signals continued demand for portable, connected devices used in asthma, COPD and other chronic respiratory conditions.

What happened: - The Business Research Company released a 2026 nebulizers market report covering market size, trends and a global forecast through 2035. - The report says the nebulizers market increased from $1.4 billion in 2025 to an expected $1.52 billion in 2026. - The report projects the market will reach $2.07 billion by 2030, implying an 8.1% compound annual growth rate through that period. - North America held the largest share of the global nebulizers market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - The report links recent growth to higher rates of respiratory illness, more home healthcare, wider hospital use of respiratory devices, better aerosol drug delivery technology and greater patient awareness. - The forecast points to demand from remote patient monitoring, connected medical devices, home chronic disease management, pediatric care and elder care. - The report highlights portable and smart nebulizers, app-enabled devices, mesh nebulizer technology and compact designs as major trends. - Nebulizers deliver medication in aerosol form to the lungs and are used to treat conditions including asthma, cystic fibrosis and chronic obstructive pulmonary disease. - The report says nebulizers help manage symptoms and improve lung function through targeted drug delivery. - The company also says the 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample report and the full market report are available online.

Between the lines: - The market thesis leans heavily on care moving out of hospitals and into homes, where connected devices and adherence tools can support long-term treatment. - Telemedicine adoption is a key demand signal because remote consultations make nebulizer therapy easier to integrate into ongoing care plans. - FAIR Health reported that telemedicine claim lines rose from 5.5% in December 2022 to 5.9% in January 2023, a 7.3% national increase.

What's next: - Growth is likely to stay tied to chronic respiratory disease management, especially for patients who need frequent treatment outside traditional clinical settings. - Product development will likely focus on smaller, smarter and more patient-friendly nebulizers as manufacturers compete on convenience and adherence. - Asia-Pacific’s expected outperformance suggests the market’s next phase of expansion may come from rising healthcare access and device adoption across the region.